Tonje Braaten

Associate professor II

Nord University
Country flagNorway

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (13)

Year:

2026

Year:

2026

Year:

2026

Objective The prevalence of eating disorders (EDs) is increasing, but little is known about their trends among university students, particularly following COVID-19. This study examines prevalence in EDs and disordered eating (DE) symptoms among students in 2018 and 2022, focusing on gender and socio-demographic disparities. Methods Data were drawn from the Students’ Health and Well-being Study (SHoT) in 2018 ( n = 50 054) and 2022 ( n = 59 544), a large-scale Norwegian survey covering full-time university students aged 18–36. Participants completed self-report measures assessing symptoms of DE (EDS scale) and ED diagnoses, socio-demographic variables, lifestyle, gender identity and financial status. Statistical analyses included logistic regression to assess associations between factors known to be linked to DE and EDs, chi-square tests for group comparisons, and t-tests for continuous variables. Results From 2018 to 2022, the prevalence of self-reported EDs increased among females (3.5% in 2018 and 4.5% in 2022) and males (0.4% in 2018 and 0.6% in 2022), while gender-diverse students exhibited the overall highest ED rates (around 10% in both surveys). Anorexia nervosa remained the most common ED among females. Daily/almost daily exercise, financial difficulties, loneliness, and living alone were closely linked to EDs, odds ratios (ORs) ranging from 1.3 to 3.7 in females. Similar patterns were seen for female DE cases. Although numbers were low, financial difficulties and particularly loneliness indicated higher risk for DE and any EDs among males. Discussion The findings suggest a relative rise in ED prevalence among students after the COVID-19 pandemic, while DE symptoms and -cases only changed minimally. These findings highlight the need for enhanced awareness and student mental health services, particularly for gender-diverse individuals, and to improve early detection and intervention strategies among those facing financial hardship and loneliness.

Year:

2025

Background Adolescent mental health problems and mental health help-seeking have increased in the later decades. We aimed to assess to which extent adolescents with high mental health symptom loads received help in general practice or specialist mental health services, and whether parental education influenced the association. Methods This cohort study included 7554 Norwegian adolescents who participated in the population-based Young-HUNT4 Survey (2017–2019). They reported their mental health by the Strengths and Difficulties Questionnaire (SDQ), measuring both internalising and externalising symptoms, summed up to a Total Difficulties score. During 1 year after participation, data on contacts with and diagnoses from general practice and specialist mental health services were collected from national registries. We used generalised linear models to analyse the probability of contact with general practice and specialist mental health services by low, moderate and high SDQ scores. We evaluated effect measure modification using interaction terms. Results Among adolescents with high total, internalising or externalising SDQ scores, 29–31% of females and 19–21% of males consulted a general practitioner for mental health problems, compared with 9–10% and 6–7% among those with low scores. Males and females with high internalising scores had a nine times increased risk of specialist mental health service contacts with internalising diagnoses, and similar associations were found for externalising scores and contacts/diagnoses. The associations were largely independent of parental education level. Conclusion Adolescents’ mental health symptom loads were positively associated with health service use in general practice and specialist mental health services and largely independent of parental education.

Year:

2025

Background Multiple sclerosis (MS) is a chronic neurological disease of the central nervous system, primarily affecting young adults. Common challenges in MS include fatigue, physical impairments, and cognitive impairments, associated with low levels of physical activity, unemployment, reduced health-related quality of life (HRQoL), and substantial personal and societal costs. Many leave the workforce or reduce hours even when disability is low and despite a desire to increase work hours if the job is adjusted to their needs. Existing services aiming to optimize physical functions and work participation only initiate retrospectively, and there is a lack of knowledge regarding the possible effect of more proactive services. Objective The objective of this study is to investigate the effects of a comprehensive multidisciplinary intervention, CoreDISTparticipation, delivered across health care levels (hospitals and municipalities) and sectors (health and employment/welfare), on barriers to work, physical activity, and physical functions; fatigue; and HRQoL for employed people with multiple sclerosis (pwMS) and to perform a health economic evaluation. Methods This prospective, single-blinded randomized controlled trial (RCT) will include 115 pwMS with Expanded Disability Status Scale (EDSS) scores of 0-4 randomly allocated to either a CoreDISTparticipation intervention group or usual care (control group). The CoreDISTparticipation intervention includes (1) information videos, hospital outpatient physiotherapist assessments, and meetings with employment consultants; (2) group-based physiotherapy in municipalities for 60 minutes over 6 weeks, one indoor CoreDIST balance session, one outdoor CoreDIST balance and high-intensity interval session, and tailored work follow-up; and (3) 6 weeks of digitally supported independent training, twice weekly. Assessments will be conducted at baseline, week 9, and week 16. Primary outcomes include Multiple Sclerosis Work Difficulties Questionnaire-23 – Norwegian version (MSWDQ-23NV) and ActiGraph wGT3x-BT monitor scores. Secondary outcomes include Trunk Impairment Scale – modified Norwegian Version (TIS-modNV), Mini Balance Evaluation Systems Test (MiniBESTest), AccuGait Optimized force platform, 6-minute walk test (6MWT), Multiple Sclerosis Walking Scale‐12, Multiple Sclerosis Impact Scale-29 – Norwegian version, EQ-5D-5L, and Fatigue Severity Scale – Norwegian version scores. The study will identify effects of CoreDISTparticipation versus usual care on work barriers, physical activity, balance, walking, fatigue, and quality of life, along with a health economic evaluation. Descriptive statistics and repeated measures mixed models will be performed using IBM SPSS version29. Results We completed the enrolment phase and enrolled and randomized 115 participants in two phases by August 1, 2024. The 15-week retests were completed in December 2024, and data collection is estimated to be completed by September 2025. Results are expected to be published in the first quarter of 2026. Conclusions CoreDISTparticipation is an innovative approach proactively addressing physical functions, physical activity, and work participation. If effective, it can offer a low-cost approach that potentially may enhance the quality of life and workforce sustainability and reduce societal costs. Trial Registration ClinicalTrials.gov NCT06110468; https://www.clinicaltrials.gov/study/NCT06110468 International Registered Report Identifier (IRRID) DERR1-10.2196/74988

Year:

2025

Year:

2025

Objectives Self-rated health (SRH) is a well-established predictor of all-cause mortality. However, its predictive value in patients with cancer remains unclear. We aimed to elucidate the relationship between prediagnostic SRH and mortality among patients with cancer using data from the Norwegian Women and Health (NOWAC) Study. Design A prospective cohort study. Settings and participants This study included 26 405 women from the NOWAC cohort who were diagnosed with cancer between 1992 and 2020. Subgroup analyses focused on the most common cancer types among Norwegian women: breast (n=8299), colorectal (n=3653) and lung and bronchial (n=2428) cancers. Primary and secondary outcome measures Prediagnostic SRH was assessed using a single-item measure with four response alternatives and categorised into ‘very good’, ‘good’ and ‘poor’ SRH. We used flexible parametric survival analysis and competing risk regression models to evaluate the association between SRH and all-cause and cancer-specific mortality after adjusting for age, physical activity, Body Mass Index, smoking, alcohol consumption and education. Results Poor prediagnostic SRH was associated with increased all-cause mortality among long-term cancer survivors. For specific cancer sites, the adjusted HRs and 95% CI for poor versus very good SRH were 1.29 (95% CI: 1.06 to 1.58) for breast cancer and 1.50 (95% CI: 1.20 to 1.88) for colorectal cancer. These associations were more pronounced among long-term survivors than short-term survivors. No association was observed between prediagnostic SRH and mortality for patients with lung cancer. For cancer-specific mortality, prediagnostic SRH predicted mortality from all cancers, as well as from colorectal cancer. Conclusions Prediagnostic SRH is a significant predictor of mortality in patients with cancer, particularly among long-term survivors. These findings indicate the potential of SRH as a predictive tool for mortality, underscoring the importance of integrating SRH assessments into identifying individuals at higher risk of mortality and highlighting the potential benefits of public health interventions aimed at improving overall health, but further studies are required to assess the effect of such interventions on SRH.

Year:

2025

Background: Current epidemiologic evidence indicates that smoking is associated with a lower endometrial cancer risk. However, it is unknown if this association is causal or confounded. To further elucidate the role of smoking in endometrial cancer risk, we conducted complementary observational and Mendelian randomization (MR) analyses. Methods: The observational analyses included 286,415 participants enrolled in the European Prospective Investigation into Cancer and Nutrition and 179,271 participants in the UK Biobank, and multivariable Cox proportional hazards models were used. In two-sample MR analyses, genetic variants robustly associated with lifetime amount of smoking ( n = 126 variants) and ever having smoked regularly ( n = 112 variants) were selected and their association with endometrial cancer risk (12,906 cancer/108,979 controls from the Endometrial Cancer Association Consortium) was examined. Results: In the observational analysis, lifetime amount of smoking and ever having smoked regularly were associated with a lower endometrial cancer risk. In the MR analysis accounting for body mass index, a genetic predisposition to a higher lifetime amount of smoking was not associated with endometrial cancer risk (OR per 1-SD increment: 1.15; 95% confidence interval: 0.91–1.44). Genetic predisposition to ever having smoked regularly was not associated with risk of endometrial cancer. Conclusions: Smoking was inversely associated with endometrial cancer in the observational analyses, although unsupported by the MR. Additional studies are required to better understand the possible confounders and mechanisms underlying the observed associations between smoking and endometrial cancer. Impact: The results from this analysis indicate that smoking is unlikely to be causally linked with endometrial cancer risk.

Year:

2025

Background: Many studies have shown that socioeconomic position (SEP) is associated with the incidence of malignant tumors at different sites. This study aims to estimate the association between educational level (as proxy for SEP) and cancer incidence and to understand whether the observed associations might be partially explained by lifestyle behaviors. Methods: The analyses were performed on data from the European Prospective Investigation into Cancer and Nutrition (EPIC) study, globally and by sex. We used Cox proportional hazards models together with mediation analysis to disentangle the total effect (TE) of educational level [measured through the Relative Index of Inequality (RII)] on cancer incidence into pure direct (PDE) and total indirect (TIE) effect, unexplained and explained by mediators, respectively. PDE and TIE were then combined to compute the proportions mediated (PM). Results: After an average of 14 years of follow-up, 52,422 malignant tumors were ascertained. Low educated participants showed higher risk of developing stomach, lung, kidney (in women), and bladder (in men) cancers, and, conversely, lower risk of melanoma and breast cancer (in post-menopausal women), when compared with more educated participants. Mediation analyses showed that portions of the TE of RII on cancer could be explained by site-specific related lifestyle behaviors for stomach, lung, and breast (in women). Conclusions: Cancer incidence in Europe is determined at least in part by a socioeconomically stratified distribution of risk factors. Impact: These observational findings support policies to reduce cancer occurrence by altering mediators, such as lifestyle behaviors, particularly focusing on underprivileged strata of the population.

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Collaborators (41)

Annika Idahl

Umea University

SWEDEN
View details

Marc Gunter

International Agency for Research on Cancer

FRANCE
View details

Ben Lacey

-

UNITED KINGDOM
View details

Hans Olav Melberg

Research director

Norwegian Institute of Public Health

NORWAY
View details

Kirsti Kvaløy

Professor

Norwegian University of Science and Technology

NORWAY
View details

Naomi Allen

University of Oxford

UNITED KINGDOM
View details

Marianne Sivertsen

Associate Professor

Nord University

NORWAY
View details

Carlotta Sacerdote

Docenti di ruolo di Ia fascia

Università degli Studi del Piemonte Orientale Amedeo Avogadro

ITALY
View details

Kristin Benjaminsen Borch

Associate professor and Research group leader Systems Epidemiology

UiT The Arctic University of Norway

NORWAY
View details

Anne Tjonneland

Professor

Københavns Universitet

DENMARK
View details

Fulvio Ricceri

University of Turin

ITALY
View details

Christina Dahm

VIP, Professor

Aarhus University

DENMARK
View details

Marit B. Veierød

Professor

University of Oslo

NORWAY
View details

Tracy O'Mara

Team Head

QIMR Berghofer Medical Research Institute

AUSTRALIA
View details

Sophia Harlid

Umea University

SWEDEN
View details

Kim Overvad

Aarhus University

DENMARK
View details

Matthias B. Schulze

German Institute of Human Nutrition

GERMANY
View details

Geert Verheyden

Stroke Rehabilitation Research Lead

KU Leuven

BELGIUM
View details

Heather Ward

Imperial College London

UNITED KINGDOM
View details

Inger Torhild Gram

Professor

UiT The Arctic University of Norway

NORWAY
View details

Bent Martin Eliassen Strandås

Associate Professor

Nord University

NORWAY
View details

Claudia Giachino

University of Turin

ITALY
View details

Manuela Bergmann

senior scientist

German Institute of Human Nutrition

GERMANY
View details

Børge Sivertsen

Senior researcher

Norwegian University of Science and Technology

NORWAY
View details

Craig Olsson

Professor

Deakin University

AUSTRALIA
View details

Alicia Heath

Imperial College London

UNITED KINGDOM
View details

Renée Fortner

Head of Division

Deutsches Krebsforschungszentrum

GERMANY
View details

Vittorio Perduca

Université Paris Cité

FRANCE
View details

Gianluca Severi

University of Firenze

ITALY
View details

Elom K Aglago

Imperial College London

UNITED KINGDOM
View details

Adele Green

-

UNITED KINGDOM
View details

Nicola Bondonno

Adjunct Lecturer

Edith Cowan University

AUSTRALIA
View details

Aurora Perez-Cornago

University of Oxford

UNITED KINGDOM
View details

Marina Kvaskoff

-

FRANCE
View details

Gunnhild Åberge Vie

Norwegian University of Science and Technology

NORWAY
View details

Mattias Johansson

Scientist

International Agency for Research on Cancer

FRANCE
View details

Pietro Ferrari

Branch Head

International Agency for Research on Cancer

FRANCE
View details

alessandra macciotta

University of Turin

ITALY
View details

Corina S. Rueegg

University of Oslo

NORWAY
View details

Gørill Haugan

Professor

Nord University

NORWAY
View details

Domenico PALLI

Head

Institute for Cancer Research, Prevention and Clinical Network-ISPRO

ITALY
View details